We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$103M
AUM Growth
-$3.49M
Cap. Flow
+$1.16M
Cap. Flow %
1.13%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$6.16M
2
TXG icon
10x Genomics
TXG
+$930K

Top Sells

Rank Stock Value
1
ADPT icon
Adaptive Biotechnologies
ADPT
+$5.42M
2
QTRX icon
Quanterix
QTRX
+$513K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
1
Natera
NTRA
$46.9B
$54.5M 52.98%
503,094
– –
GH icon
2
Guardant Health
GH
$21.9B
$16.5M 16.04%
571,047
– –
AKYA
3
DELISTED
Akoya BioSciences
AKYA
$11M 10.69%
4,697,785
– –
CDNA icon
4
CareDx
CDNA
$2.41B
$7.92M 7.7%
+510,000
New +$6.16M
TXG icon
5
10x Genomics
TXG
$8.1B
$4.47M 4.35%
230,000
+35,500
+18% +$930K
QTRX icon
6
Quanterix
QTRX
$140M
$3.68M 3.58%
278,393
-30,700
-10% -$513K
EXAS
7
DELISTED
Exact Sciences
EXAS
$2.42M 2.36%
57,343
– –
MXCT icon
8
MaxCyte
MXCT
$143M
$2.37M 2.3%
603,937
– –
ADPT icon
9
Adaptive Biotechnologies
ADPT
$4.07B
– –
-1,687,665
Closed -$5.42M

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Blue Water Life Science Advisors held 9 positions worth $103M, down 3.3% from $106M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors's Q2 2024 filing shows 1 new, 1 increased, 1 reduced and 1 closed positions. Its largest new stake was CareDx: 510,000 shares worth $7.92M. The largest sale was Adaptive Biotechnologies, an estimated $5.42M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Blue Water Life Science Advisors's largest Q2 2024 buy was CareDx: 510,000 shares worth $7.92M.
  • Blue Water Life Science Advisors added most to 10x Genomics in Q2 2024, an estimated $930K increase.
  • Blue Water Life Science Advisors's biggest Q2 2024 reduction was Quanterix, cutting an estimated $513K.
  • Blue Water Life Science Advisors fully exited Adaptive Biotechnologies in Q2 2024, selling an estimated $5.42M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $103M portfolio in Q2 2024.
  • Blue Water Life Science Advisors opened 1 new position and closed 1 in Q2 2024.
  • Blue Water Life Science Advisors's portfolio value fell 3.3% quarter-over-quarter to $103M.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.